GLP-1 Peripregnancy, Normal Tissue Characterization, and CVD Risk Assessment
This week's topics include decentralized clinical trials, GLP-1 peripregnancy, LLM and normal tissue characterization, and texting to improve CVD risk assessment.
Program notes:
0:40 CVD risk factors and texting
1:40 How many undergo screening?
2:41 Impact of personalized messaging
3:25 Decentralized trials versus centralized
4:25 Decentralized much larger
5:25 Does the trial move in one way or another?
6:15 Two studies related to use of peripregnancy GLP-1 use
7:15 Stopping at pregnancy
8:15 Is overweight worse than stopping?
9:00 Machine learning model, tissues, genetics and age
10:00 Practical for assessing genetic basis
11:00 Sequential tissue samples
11:57 End